Dynamic Nanopeptide Assemblies for Trans-Tympanic Drug Delivery
Evan A Patel1, Swapnil V Shah1, Trevor A Poulson1
1Department of Otolaryngology, Head and Neck Surgery, Rush University Medical Center, Chicago, IL, 60612, USA.
International Journal of Nanomedicine
|July 29, 2025
Summary
Researchers developed a novel peptide hydrogel for non-invasive drug delivery across the tympanic membrane. This hydrogel releases ciprofloxacin and acts as a cell-penetrating peptide (CPP) for otitis media treatment.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Otitis media is a prevalent global condition requiring effective treatment strategies.
- Current treatment methods for otitis media often involve invasive procedures.
- Trans-tympanic membrane drug delivery is hindered by the tympanic membrane's thickness.
Purpose of the Study:
- To develop a non-invasive drug delivery system for otitis media.
- To engineer a peptide-based hydrogel for enhanced trans-tympanic membrane drug delivery.
- To investigate the controlled release of ciprofloxacin from a peptide hydrogel.
Main Methods:
- Synthesized peptides using automated solid-phase peptide synthesis.
- Formulated peptide amphiphile hydrogels incorporating ciprofloxacin.
- Assessed ciprofloxacin release kinetics over 48 hours.
- Evaluated cytotoxicity using epidermal keratinocyte viability assays.
- Utilized laser scanning confocal microscopy for material characterization.
Main Results:
- Demonstrated a self-assembling peptide amphiphile hydrogel that transitions between fiber and micelle structures.
- The hydrogel functions as an effective cell-penetrating peptide (CPP).
- Achieved temporal control over the release of the antibiotic ciprofloxacin.
- Confirmed the biocompatibility of the peptide amphiphile (PA) micelle and fiber.
Conclusions:
- Engineered peptide hydrogels show potential for trans-tympanic membrane drug delivery.
- The dynamic dissociation of the hydrogel into CPPs facilitates drug transport.
- This approach offers a promising non-invasive strategy for treating otitis media.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
126
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
126
Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
Site-Targeted Drug Delivery Systems: Polymeric Carriers
117
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
117
Transdermal Drug Delivery Systems
180
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
180


